Medicine use for headache in adolescence predicts medicine use for headache in young adulthood

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Medicine use for headache in adolescence predicts medicine use for headache in young adulthood. / Andersen, Anette; Holstein, Bjørn E; Due, Pernille; Hansen, Ebba Holme.

I: Pharmacoepidemiology and Drug Safety, Bind 18, Nr. 7, 2009, s. 619-23.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Andersen, A, Holstein, BE, Due, P & Hansen, EH 2009, 'Medicine use for headache in adolescence predicts medicine use for headache in young adulthood', Pharmacoepidemiology and Drug Safety, bind 18, nr. 7, s. 619-23. https://doi.org/10.1002/pds.1748

APA

Andersen, A., Holstein, B. E., Due, P., & Hansen, E. H. (2009). Medicine use for headache in adolescence predicts medicine use for headache in young adulthood. Pharmacoepidemiology and Drug Safety, 18(7), 619-23. https://doi.org/10.1002/pds.1748

Vancouver

Andersen A, Holstein BE, Due P, Hansen EH. Medicine use for headache in adolescence predicts medicine use for headache in young adulthood. Pharmacoepidemiology and Drug Safety. 2009;18(7):619-23. https://doi.org/10.1002/pds.1748

Author

Andersen, Anette ; Holstein, Bjørn E ; Due, Pernille ; Hansen, Ebba Holme. / Medicine use for headache in adolescence predicts medicine use for headache in young adulthood. I: Pharmacoepidemiology and Drug Safety. 2009 ; Bind 18, Nr. 7. s. 619-23.

Bibtex

@article{f53f40e0801711de8bc9000ea68e967b,
title = "Medicine use for headache in adolescence predicts medicine use for headache in young adulthood",
abstract = "BACKGROUND: Health risk behaviours such as smoking and binge drinking track from adolescence to adulthood. Medicine use is associated with smoking and binge drinking among adolescents. Whether medicine-use behaviour tracks from adolescence to adulthood is unknown. AIM: To examine tracking of medicine use for headache from age 15 to 19 to 27. METHODS: A national random sample of 15-year-olds (n = 996) was followed up after four and twelve years respectively in a longitudinal study in Denmark; 614 persons completed questionnaires in all three waves. The main outcome measure was medicine use for headache within the past 14 days. RESULTS: Medicine use for headache was common in all age groups and more females than males used medicine in all three age groups: 34.9% vs. 18.0% at age 15, 45.4% vs. 22.1% at age 19 and 44.3% vs. 29.5% at age 27. The risk of using medicine for headache at age 27 increased if medicine was used at age 15 or 19. However, use increased substantially if medicine for headache was used at both age 15 and 19 (OR = 5.83, 95%CI: 1.99-17.14 for males and OR = 4.67, 95%CI: 2.59-8.43 for females). CONCLUSION: Medicine use for headache is a behavioural pattern that may track from adolescence into adulthood.",
keywords = "Former Faculty of Pharmaceutical Sciences",
author = "Anette Andersen and Holstein, {Bj{\o}rn E} and Pernille Due and Hansen, {Ebba Holme}",
note = "(c) 2009 John Wiley & Sons, Ltd.",
year = "2009",
doi = "10.1002/pds.1748",
language = "English",
volume = "18",
pages = "619--23",
journal = "Pharmacoepidemiology and Drug Safety",
issn = "1053-8569",
publisher = "JohnWiley & Sons Ltd",
number = "7",

}

RIS

TY - JOUR

T1 - Medicine use for headache in adolescence predicts medicine use for headache in young adulthood

AU - Andersen, Anette

AU - Holstein, Bjørn E

AU - Due, Pernille

AU - Hansen, Ebba Holme

N1 - (c) 2009 John Wiley & Sons, Ltd.

PY - 2009

Y1 - 2009

N2 - BACKGROUND: Health risk behaviours such as smoking and binge drinking track from adolescence to adulthood. Medicine use is associated with smoking and binge drinking among adolescents. Whether medicine-use behaviour tracks from adolescence to adulthood is unknown. AIM: To examine tracking of medicine use for headache from age 15 to 19 to 27. METHODS: A national random sample of 15-year-olds (n = 996) was followed up after four and twelve years respectively in a longitudinal study in Denmark; 614 persons completed questionnaires in all three waves. The main outcome measure was medicine use for headache within the past 14 days. RESULTS: Medicine use for headache was common in all age groups and more females than males used medicine in all three age groups: 34.9% vs. 18.0% at age 15, 45.4% vs. 22.1% at age 19 and 44.3% vs. 29.5% at age 27. The risk of using medicine for headache at age 27 increased if medicine was used at age 15 or 19. However, use increased substantially if medicine for headache was used at both age 15 and 19 (OR = 5.83, 95%CI: 1.99-17.14 for males and OR = 4.67, 95%CI: 2.59-8.43 for females). CONCLUSION: Medicine use for headache is a behavioural pattern that may track from adolescence into adulthood.

AB - BACKGROUND: Health risk behaviours such as smoking and binge drinking track from adolescence to adulthood. Medicine use is associated with smoking and binge drinking among adolescents. Whether medicine-use behaviour tracks from adolescence to adulthood is unknown. AIM: To examine tracking of medicine use for headache from age 15 to 19 to 27. METHODS: A national random sample of 15-year-olds (n = 996) was followed up after four and twelve years respectively in a longitudinal study in Denmark; 614 persons completed questionnaires in all three waves. The main outcome measure was medicine use for headache within the past 14 days. RESULTS: Medicine use for headache was common in all age groups and more females than males used medicine in all three age groups: 34.9% vs. 18.0% at age 15, 45.4% vs. 22.1% at age 19 and 44.3% vs. 29.5% at age 27. The risk of using medicine for headache at age 27 increased if medicine was used at age 15 or 19. However, use increased substantially if medicine for headache was used at both age 15 and 19 (OR = 5.83, 95%CI: 1.99-17.14 for males and OR = 4.67, 95%CI: 2.59-8.43 for females). CONCLUSION: Medicine use for headache is a behavioural pattern that may track from adolescence into adulthood.

KW - Former Faculty of Pharmaceutical Sciences

U2 - 10.1002/pds.1748

DO - 10.1002/pds.1748

M3 - Journal article

C2 - 19358227

VL - 18

SP - 619

EP - 623

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 7

ER -

ID: 13524685